skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ScienceDirect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
1030P - Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
1030P - Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1030P - Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)

Monk, B.J. ; Herzog, T.J. ; Triantos, S. ; Maul, S. ; Wang, G. ; Valero, M J Pontes ; McGowan, T. ; Shalaby, W.S. ; Coleman, R.L.

Annals of oncology, 2019-10, Vol.30, p.v420-v421 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
12
1030PImpact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
1030PImpact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1030PImpact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)

Monk, B J ; Herzog, T J ; Triantos, S ; Maul, S ; Wang, G ; Valero, M J Pontes ; McGowan, T ; Shalaby, W S ; Coleman, R L

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
13
1059TiP - Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
1059TiP - Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

1059TiP - Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study

Vergote, I.B. ; Copeland, L. ; Monk, B.J. ; Coleman, R.L. ; Cibula, D. ; Sehouli, J. ; Samartzis, E.P. ; Radoslaw, M. ; Martín, A González ; Korach, J. ; Salutari, V. ; Witteveen, P.O. ; O’Malley, D.

Annals of oncology, 2019-10, Vol.30, p.v431-v431 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
14
1059TiPTumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
1059TiPTumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

1059TiPTumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study

Vergote, I B ; Copeland, L ; Monk, B J ; Coleman, R L ; Cibula, D ; Sehouli, J ; Samartzis, E P ; Radoslaw, M ; Martín, A González ; Korach, J ; Salutari, V ; Witteveen, P O ; O’Malley, D

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
15
1072 Functional outcomes in contemporary high-risk prostate cancer treated by open or minimally invasive radical prostatectomy between 2003 and 2012
1072 Functional outcomes in contemporary high-risk prostate cancer treated by open or minimally invasive radical prostatectomy between 2003 and 2012
Material Type:
Artigo 		Adicionar ao Meu Espaço

1072 Functional outcomes in contemporary high-risk prostate cancer treated by open or minimally invasive radical prostatectomy between 2003 and 2012

Passoni, N.M ; Kimm, S ; Bernstein, M ; Coleman, J.A ; Laudone, V.P ; Parra, R.O ; Sandhu, J.S ; Eastham, J.A ; Scardino, P.T ; Touijer, K.A

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e1072-e1072

Elsevier B.V

Texto completo disponível

Citações Citado por
16
108. Neurocognitive predictors of functional decline in poor-outcome schizophrenia
108. Neurocognitive predictors of functional decline in poor-outcome schizophrenia
Material Type:
Artigo 		Adicionar ao Meu Espaço

108. Neurocognitive predictors of functional decline in poor-outcome schizophrenia

Moriarty, P.J. ; Coleman, T. ; Friedman, J. ; Harvey, P.D. ; Bowie, C.R. ; White, L. ; Parella, M. ; Davis, K.L.

Biological psychiatry (1969), 2000-04, Vol.47 (8), p.S33-S33 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
17
1090: The Effect of Radiofrequency Ablation of Renal Tumors on Renal Function
1090: The Effect of Radiofrequency Ablation of Renal Tumors on Renal Function
Material Type:
Artigo 		Adicionar ao Meu Espaço

1090: The Effect of Radiofrequency Ablation of Renal Tumors on Renal Function

Lee, S. Justin ; Bratslavsky, Gennady ; Venzon, David ; Peterson, James ; Gautam, Rabindra ; Pinto, Peter A. ; Choyke, Peter L. ; Wood, Bradford J. ; Walther, McClellan M. ; Linehan, W. Marston ; Coleman, Jonathan A.

The Journal of urology, 2006-04, Vol.175 (4), p.350-351 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
18
10th Annual scientific session September 29-October 2, 2005 Seattle, Washington
10th Annual scientific session September 29-October 2, 2005 Seattle, Washington
Material Type:
Artigo 		Adicionar ao Meu Espaço

10th Annual scientific session September 29-October 2, 2005 Seattle, Washington

Hacker, M ; Jakobs, T ; Becker, C ; Pfluger, T ; Woo, A ; Masry, Hz El ; Kalaria, Vg ; Virnich, De ; Williams, Ka ; Spencer, Kt ; Zervos, Gd ; Yasuda, T ; Croft, Lb ; Pungoti, C ; Henzlova, Mj ; Hage, Fg ; Wu, E ; Smanio, P ; Rodrigues, F ; Thorn, A ; Mello, R ; Visser, Fc ; Verzijlbergen, Jf ; van Hemel, Nm ; Heller, Gv ; Stier, A ; Cerci, Ms ; Ribeiro, Of ; Grasman, Me ; Dim, U ; Nagar, K ; Raval, U ; Lahiri, A ; van Domburg, Rt ; Poldermans, D ; Heiba, Si ; Katzel, Ja ; Milarodovic, R ; Abdel-dayem, Ha ; Coppola, J ; Heston, Tf ; Høilund-carlsen, Pf ; Johansen, A ; Haghfelt, T ; Byrne, D ; Bergmann, Sr ; Gopal, As ; Ngai, K ; Chen, J ; Lacy, J ; Cortsen, A ; Carboni, Gp ; Okino, S ; Ichikawa, S ; Gutierrez, Fr ; Zheng, J ; Gropler, Rj ; Woodard, Pk ; Lerakis, S ; Ramrakhiani, S ; Stricker, Sl ; Richards, Dr ; Bhama, A ; Goetze, S ; Elmquist, T ; Hsu, Bl ; Moser, Kw ; Stoner, C ; Matsumoto, N ; Muromoto, M ; Kaminski, Rj ; Oaknin, Jh ; Shwartz, Sc ; Coleman, Re ; Cullom, Sj ; Mcghie, Ai ; Devabhaktuni, M ; Hickey, Kt ; Bokhari, S ; Almeida, D ; Kanayama, S ; Satake, O ; Hertenstein, Gk ; Volker, Ll ; Folks, Rd ; Clements, Ip ; Lacourcière, Y ; Aqel, Ra ; Clay, Ma ; Kim, N-b ; Vedala, G ; Del Priore, E ; Tomlinson, Gc ; Cunningham, Ms ; Guilarte, Nm ; Lundbye, Jb ; Ahlberg, A ; Boden, We ; Paiesdana, A ; Murthy, Dr

Journal of nuclear cardiology, 2005-07, Vol.12 (4), p.S100 [Periódico revisado por pares]

New York: Springer Nature B.V

Texto completo disponível

Citações Citado por
19
11 - A phase I trial of mesenchymal stem cells transfected with a plasmid secreting interferon beta in advanced ovarian cancer
11 - A phase I trial of mesenchymal stem cells transfected with a plasmid secreting interferon beta in advanced ovarian cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

11 - A phase I trial of mesenchymal stem cells transfected with a plasmid secreting interferon beta in advanced ovarian cancer

Olson, A. ; Marini, F. ; Westin, S. ; Coleman, R. ; Thall, P. ; Al Jahdami, V. ; Qazilbash, M. ; Rezvani, K. ; Timmons, M. ; Heese, L. ; Wang, R. ; Champlin, R. ; Shpall, E. ; Andreeff, M.

Cytotherapy (Oxford, England), 2018-05, Vol.20 (5), p.S11-S12 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
20
11 - Are the Cardiovascular (CV) Risk Reductions Seen with Empagliflozin in the EMPA-REG OUTCOME Trial Explained by Conventional CV Risk Factors?
11 - Are the Cardiovascular (CV) Risk Reductions Seen with Empagliflozin in the EMPA-REG OUTCOME Trial Explained by Conventional CV Risk Factors?
Material Type:
Artigo 		Adicionar ao Meu Espaço

11 - Are the Cardiovascular (CV) Risk Reductions Seen with Empagliflozin in the EMPA-REG OUTCOME Trial Explained by Conventional CV Risk Factors?

Broedl, Uli C. ; Fitchett, David ; Coleman, Ruth L. ; Gray, Alastair M. ; George, Jyothis T. ; Woerle, Hans J. ; Zinman, Bernard ; Holman, Rury R.

Canadian journal of diabetes, 2017-10, Vol.41 (5), p.S5-S5 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (4.715)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (4.860)
  2. Anais de Congresso  (24)
  3. Book Chapters  (11)
  4. Reports  (9)
  5. Outros  (5)
  6. Resenhas  (4)
  7. magazinearticle  (3)
  8. Recursos Textuais  (2)
  9. Web Resources  (1)
  10. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1963  (42)
  2. 1963Até1977  (158)
  3. 1978Até1992  (706)
  4. 1993Até2008  (1.614)
  5. Após 2008  (2.402)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (4.907)
  2. Japonês  (556)
  3. Espanhol  (5)
  4. Francês  (3)
  5. Norueguês  (3)
  6. Persa  (2)
  7. Russo  (1)
  8. Alemão  (1)
  9. Coreano  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.